Insulin resistance in perimenopause: the metabolic shift that changes everything
For many women in their 40s, the number on the scale isn't the first thing that changes. The chemistry changes first.
TL;DR
- Estrogen directly influences how sensitive your cells are to insulin. When estrogen fluctuates in perimenopause, insulin sensitivity often declines.
- This shift can begin years before a formal menopause diagnosis and often shows up as abdominal weight gain without obvious cause.
- It is visible on standard lab panels — fasting glucose, fasting insulin, HbA1c, and triglycerides — before symptoms become obvious.
What it is
Insulin resistance (in plain English: when your cells stop responding well to insulin, the hormone that moves blood sugar into cells for energy) is a metabolic state that precedes type 2 diabetes — often by a decade or more. It is common in the general population, but it becomes significantly more common in women during perimenopause.
Think of insulin as a key and your cells as locks. In insulin resistance, the locks get stiff. Your pancreas makes more keys to compensate, but eventually the system starts to strain.
How estrogen drives the shift
Estrogen receptors (in plain English: proteins inside cells that respond to estrogen signals) are present in muscle, liver, and fat tissue. When estrogen is stable and adequate, it helps keep those cells responsive to insulin. When estrogen begins to fluctuate — as it does in the years before menopause — that protection starts to fade.
Fat redistribution follows: rather than accumulating on hips and thighs, fat increasingly settles around the abdomen. Visceral fat (in plain English: fat stored around internal organs, not under the skin) is metabolically active — it releases inflammatory signals that make insulin resistance worse.
What the research says
A 2022 review in the Menopause journal found that the perimenopausal transition is associated with a significant increase in insulin resistance independent of age and body weight. About 6 in 10 women who develop metabolic syndrome (a cluster of five cardiovascular and metabolic risk factors) do so during or after perimenopause.
NHANES (the National Health and Nutrition Examination Survey — a CDC program tracking health trends) data consistently shows that fasting insulin levels rise in the 40–55 age window for women at a steeper rate than for men of the same age.
What to know before considering it
Insulin resistance in perimenopause is not inevitable, but it is common and often overlooked. Standard wellness checkups may catch fasting glucose, but fasting insulin and HOMA-IR (a calculation combining fasting glucose and fasting insulin to estimate sensitivity) are often not included. Asking your clinician to add these to a routine panel is a reasonable and low-cost step. Any protocol addressing insulin resistance requires a physician evaluation.
Who asks about this
Women in their 40s and early 50s who have noticed unexplained weight gain — especially around the midsection — often come to this topic looking for a biological explanation. The answer is frequently in the labs.
The Halftime POV
Perimenopause is one of the most metabolically consequential transitions in a woman's life, and it happens gradually enough that many women don't connect the dots until years in. Understanding what's happening on a cellular level — and what shows up on a lab panel — turns a frustrating symptom into a solvable problem. That's exactly the kind of context proactive medicine is built around.
Related reading:
- Understanding fasting glucose and HbA1c
- Foundation biomarkers: where to start
- Baseline blood panel before starting a protocol
FAQ
Q: What is insulin resistance? A: Insulin resistance is when your cells stop responding efficiently to insulin, the hormone that moves blood sugar out of the bloodstream and into cells for energy. Your pancreas compensates by producing more insulin, but blood sugar can still rise over time.
Q: Why does perimenopause cause insulin resistance? A: Estrogen directly supports insulin sensitivity in muscle, liver, and fat cells. As estrogen fluctuates and declines during perimenopause, those cells become less responsive. This often shows up as abdominal weight gain before other symptoms appear.
Q: What lab tests detect insulin resistance? A: Key markers include fasting glucose (ideally under 100 mg/dL), fasting insulin (ideally under 10 µIU/mL), HbA1c (ideally under 5.7%), and triglycerides (under 150 mg/dL). HOMA-IR, calculated from fasting glucose and insulin, provides a combined estimate. A clinician can interpret these in your full clinical context.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. Join the waitlist and we'll email you when we're live.
Sources
- Estrogen and insulin sensitivity in perimenopause — Menopause journal, 2022
- Estrogen and metabolic syndrome risk in women — PubMed, 2012
Frequently asked questions
What is insulin resistance?
Insulin resistance is when your cells stop responding well to insulin, the hormone that moves glucose (blood sugar) out of the bloodstream and into cells for energy. Your pancreas compensates by producing more insulin, but blood sugar levels can still creep up over time.
Why does perimenopause cause insulin resistance?
Estrogen plays a direct role in insulin sensitivity. As estrogen levels fluctuate and decline during perimenopause, muscle and fat cells become less responsive to insulin. This shift can happen years before menopause and often shows up as unexplained weight gain around the abdomen.
What lab values show insulin resistance in perimenopause?
Key markers include fasting glucose (ideally under 100 mg/dL), fasting insulin (ideally under 10 µIU/mL), HbA1c (ideally under 5.7%), and triglycerides (ideally under 150 mg/dL). A HOMA-IR calculation using fasting glucose and insulin gives a combined sensitivity estimate. A clinician can interpret these in your full clinical context.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.